Abbvie (ABBV) Shareholder Howe & Rusling Has Trimmed Position as Market Valuation Rose; Quantitative Investment Management Position in Lumber Liquidators Holdings (LL) Has Lowered by $4.39 Million

December 29, 2017 - By Peter Erickson

Howe & Rusling Inc decreased its stake in Abbvie Inc (ABBV) by 7.15% based on its latest 2017Q3 regulatory filing with the SEC. Howe & Rusling Inc sold 9,212 shares as the company’s stock rose 6.17% with the market. The institutional investor held 119,548 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $10.62 million, down from 128,760 at the end of the previous reported quarter. Howe & Rusling Inc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $155.15 billion market cap company. The stock decreased 0.62% or $0.6056 during the last trading session, reaching $97.1844. About 1.14M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since December 29, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Quantitative Investment Management Llc decreased its stake in Lumber Liquidators Holdings Inc (LL) by 37.09% based on its latest 2017Q3 regulatory filing with the SEC. Quantitative Investment Management Llc sold 115,500 shares as the company’s stock rose 89.65% with the market. The hedge fund held 195,900 shares of the consumer services company at the end of 2017Q3, valued at $7.64M, down from 311,400 at the end of the previous reported quarter. Quantitative Investment Management Llc who had been investing in Lumber Liquidators Holdings Inc for a number of months, seems to be less bullish one the $901.27 million market cap company. The stock increased 0.80% or $0.25 during the last trading session, reaching $31.64. About 272,504 shares traded. Lumber Liquidators Holdings, Inc. (NYSE:LL) has risen 154.19% since December 29, 2016 and is uptrending. It has outperformed by 137.49% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.15, from 1 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings. 132 funds opened positions while 462 raised stakes. 1.06 billion shares or 1.89% more from 1.04 billion shares in 2017Q2 were reported. State Board Of Administration Of Florida Retirement Sys invested in 2.32M shares. Ipswich Management accumulated 4,420 shares. First Republic Mngmt Inc accumulated 0.78% or 1.23M shares. Fiduciary Tru Company reported 0.89% stake. Northern Tru Corp invested in 0.52% or 22.32M shares. 5,122 are owned by Strategic Serv. Mengis holds 0.88% or 14,795 shares. Suntrust Banks Inc invested in 0.54% or 1.13M shares. Webster Bank N A has 0.67% invested in AbbVie Inc. (NYSE:ABBV) for 51,829 shares. Cap Inv Of America Incorporated has invested 0.05% of its portfolio in AbbVie Inc. (NYSE:ABBV). Jones Finance Lllp invested in 33,126 shares. 8,250 were reported by Hgk Asset Management. Jacobs & Co Ca holds 75,775 shares. Wealthtrust holds 0% or 54 shares. Badgley Phelps Bell holds 3,609 shares.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28 billion for 16.99 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Since July 31, 2017, it had 0 insider purchases, and 8 selling transactions for $45.57 million activity. RICHMOND TIMOTHY J. sold 87,040 shares worth $8.57 million. On Thursday, September 28 the insider Michael Robert A. sold $589,512. 145,510 AbbVie Inc. (NYSE:ABBV) shares with value of $14.07 million were sold by Schumacher Laura J. 300 shares were sold by Gosebruch Henry O, worth $21,127 on Monday, July 31. SALEKI-GERHARDT AZITA sold $705,655 worth of AbbVie Inc. (NYSE:ABBV) on Monday, September 11.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies upgraded AbbVie Inc. (NYSE:ABBV) rating on Monday, December 7. Jefferies has “Buy” rating and $55 target. The firm has “Neutral” rating by UBS given on Monday, September 25. The stock of AbbVie Inc. (NYSE:ABBV) has “Sell” rating given on Wednesday, April 6 by Societe Generale. As per Monday, October 2, the company rating was upgraded by Leerink Swann. The rating was downgraded by JP Morgan on Thursday, September 8 to “Neutral”. The company was maintained on Friday, September 15 by Jefferies. The firm has “Market Perform” rating by Cowen & Co given on Monday, June 6. The rating was downgraded by BMO Capital Markets on Friday, June 10 to “Market Perform”. The stock has “Buy” rating by UBS on Friday, October 23. Barclays Capital maintained the stock with “Equal-Weight” rating in Friday, October 13 report.

Howe & Rusling Inc, which manages about $798.49M and $540.49M US Long portfolio, upped its stake in Cdn Imperial Bk Comm Toronto (NYSE:CM) by 4,040 shares to 95,108 shares, valued at $8.32 million in 2017Q3, according to the filing. It also increased its holding in Microsoft Corp (NASDAQ:MSFT) by 16,107 shares in the quarter, for a total of 153,052 shares, and has risen its stake in Vanguard Scottsdale Fds (VCSH).

Analysts await Lumber Liquidators Holdings, Inc. (NYSE:LL) to report earnings on February, 20. They expect $0.10 earnings per share, up 150.00% or $0.30 from last year’s $-0.2 per share. LL’s profit will be $2.85 million for 79.10 P/E if the $0.10 EPS becomes a reality. After $0.07 actual earnings per share reported by Lumber Liquidators Holdings, Inc. for the previous quarter, Wall Street now forecasts 42.86% EPS growth.

Among 12 analysts covering Lumber Liquidators Holdings (NYSE:LL), 5 have Buy rating, 1 Sell and 6 Hold. Therefore 42% are positive. Lumber Liquidators Holdings had 27 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Tuesday, August 1. The firm has “Hold” rating given on Tuesday, October 31 by Stifel Nicolaus. Morgan Stanley maintained it with “Equal-Weight” rating and $35 target in Monday, October 2 report. Jefferies maintained Lumber Liquidators Holdings, Inc. (NYSE:LL) rating on Wednesday, June 14. Jefferies has “Hold” rating and $1900 target. Oppenheimer upgraded the shares of LL in report on Friday, May 19 to “Outperform” rating. Piper Jaffray maintained Lumber Liquidators Holdings, Inc. (NYSE:LL) rating on Thursday, September 7. Piper Jaffray has “Hold” rating and $32.0 target. The stock has “Hold” rating by Piper Jaffray on Tuesday, October 31. The stock of Lumber Liquidators Holdings, Inc. (NYSE:LL) has “Buy” rating given on Friday, August 18 by Oppenheimer. The rating was maintained by Jefferies with “Hold” on Thursday, September 28. Goldman Sachs downgraded Lumber Liquidators Holdings, Inc. (NYSE:LL) on Thursday, December 17 to “Sell” rating.

Quantitative Investment Management Llc, which manages about $1.89 billion and $8.76 billion US Long portfolio, upped its stake in Resmed Inc (NYSE:RMD) by 8,000 shares to 178,500 shares, valued at $13.74M in 2017Q3, according to the filing. It also increased its holding in General Motors Co (NYSE:GM) by 602,500 shares in the quarter, for a total of 1.65 million shares, and has risen its stake in Etrade Financial Corp (NASDAQ:ETFC).